Try our beta test site
99 studies found for:    Open Studies | "Muscular Dystrophies"
Show Display Options
Rank Status Study
21 Recruiting Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: Myoblast transplantation;   Procedure: Saline injection
22 Recruiting Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Eplerenone;   Drug: Spironolactone
23 Recruiting Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life.
Condition: Duchenne Muscular Dystrophy
Intervention:
24 Recruiting Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Interventions: Other: Magnetic Resonance Imaging (MRI);   Other: Pulmonary Function Testing (PFT);   Other: Metabolic Exercise Testing using stationary bicycle;   Other: Echocardiogram
25 Recruiting Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy (DMD)
Intervention: Drug: eteplirsen
26 Recruiting 2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children
Condition: Duchenne Muscular Dystrophy
Intervention: Other: speckle tracking (2D strain) echocardiography
27 Available Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Deflazacort
28 Not yet recruiting Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: givinostat;   Drug: placebo
29 Recruiting Rimeporide in Patients With Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Rimeporide
30 Recruiting Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
Condition: Facioscapulohumeral Muscular Dystrophy
Intervention:
31 Recruiting Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD)
Condition: Facioscapulohumeral Muscular Dystrophy
Interventions: Drug: ACE-083;   Drug: ACE-083 or placebo
32 Recruiting Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy
Condition: Duchenne / Becker Muscular Dystrophy
Intervention: Other: Observation
33 Recruiting Efficacy Safety of Granulocyte Colony-stimulating Factor Treatment Children and Adolescents With Muscular Dystrophy
Condition: Increase of Muscle Strength in Patients With Muscular Dystrophy
Intervention: Drug: Granulocyte colony-stimulating factor (Filgrastim)
34 Recruiting Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Sustanon (testosterone)
35 Recruiting A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids
Condition: Duchenne Muscular Dystrophy (DMD)
Interventions: Drug: Idebenone 150 mg film-coated tablets;   Drug: placebo
36 Recruiting Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study
Condition: Duchenne Muscular Dystrophy
Intervention: Other: Set of assessment tools
37 Recruiting Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention:
38 Recruiting DuchenneConnect Registry
Conditions: Duchenne Muscular Dystrophy;   Becker Muscular Dystrophy
Intervention:
39 Recruiting PoC Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With DMD
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: ezutromid
40 Recruiting Study of Ataluren in ≥2 to <5 Year-Old Males With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Ataluren

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.